LRIG1 is a triple threat: ERBB negative regulator, intestinal stem cell marker and tumour suppressor

por Wang, Y, Poulin, E J, Coffey, R J
Publicado 2013

Roles for transforming growth factor-alpha in gastric physiology and pathophysiology.

por Coffey, R. J., Romano, M., Polk, W. H., Dempsey, P. J.
Publicado 1992

Cell-Autonomous Role of EGFR in Spontaneous Duodenal Tumors in LRIG1 Null Mice

por Niitsu, H., Lu, Y., Huh, W.J., Love, A.M., Franklin, J.L., Coffey, R.J.
Publicado 2021

Amphiregulin acts as an autocrine growth factor in two human polarizing colon cancer lines that exhibit domain selective EGF receptor mitogenesis

por Damstrup, L, Kuwada, S K, Dempsey, P J, Brown, C L, Hawkey, C J, Poulsen, H S, Wiley, H S, Coffey, R J
Publicado 1999